BX Swiss TOP 30 CHF
1.373,23
PKT
+13,12
PKT
+0,96
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 26.05.14 | UBS buy | Deutsche Bank AG | |
| 23.05.14 | Zurich Insurance buy | S&P Capital IQ | |
| 23.05.14 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 23.05.14 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 22.05.14 | UBS Hold | Commerzbank AG | |
| 22.05.14 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 22.05.14 | Holcim Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 22.05.14 | ABB (Asea Brown Boveri) Underweight | HSBC | |
| 22.05.14 | Givaudan buy | Kelper Cheuvreux | |
| 22.05.14 | Swiss Re Neutral | Citigroup Corp. | |
| 21.05.14 | ABB (Asea Brown Boveri) buy | Citigroup Corp. | |
| 20.05.14 | UBS buy | Deutsche Bank AG | |
| 20.05.14 | Nestlé buy | Société Générale Group S.A. (SG) | |
| 16.05.14 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 16.05.14 | Roche buy | UBS AG | |
| 16.05.14 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 16.05.14 | Zurich Insurance Conviction Buy List | Goldman Sachs Group Inc. | |
| 16.05.14 | Novartis buy | Société Générale Group S.A. (SG) | |
| 15.05.14 | Novartis Underweight | Morgan Stanley | |
| 15.05.14 | Roche overweight | Morgan Stanley | |
| 15.05.14 | Novartis Hold | Deutsche Bank AG | |
| 15.05.14 | Roche buy | Deutsche Bank AG | |
| 14.05.14 | Nestlé overweight | Morgan Stanley | |
| 14.05.14 | UBS buy | UBS AG | |
| 13.05.14 | Nestlé Neutral | HSBC | |
| 13.05.14 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 13.05.14 | Roche buy | Goldman Sachs Group Inc. | |
| 13.05.14 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 12.05.14 | Novartis Hold | Deutsche Bank AG | |
| 12.05.14 | Roche buy | Deutsche Bank AG | |
| 12.05.14 | Swiss Re Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 09.05.14 | Swiss Re Equal weight | Barclays Capital | |
| 08.05.14 | UBS buy | Société Générale Group S.A. (SG) | |
| 08.05.14 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
| 08.05.14 | UBS buy | Citigroup Corp. | |
| 08.05.14 | Roche buy | Kelper Cheuvreux | |
| 07.05.14 | Swiss Re verkaufen | DZ-Bank AG | |
| 07.05.14 | UBS buy | Nomura | |
| 07.05.14 | Novartis buy | UBS AG | |
| 07.05.14 | Holcim overweight | JP Morgan Chase & Co. |